SPC Financial Inc. Decreases Position in Axon Enterprise, Inc $AXON

SPC Financial Inc. trimmed its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 5.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,629 shares of the biotechnology company’s stock after selling 103 shares during the quarter. SPC Financial Inc.’s holdings in Axon Enterprise were worth $1,349,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. TCTC Holdings LLC boosted its position in Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after purchasing an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC boosted its position in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after purchasing an additional 33 shares in the last quarter. Banque Transatlantique SA purchased a new stake in Axon Enterprise during the first quarter worth $31,000. Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise during the first quarter worth $32,000. Finally, Flaharty Asset Management LLC purchased a new stake in Axon Enterprise during the first quarter worth $33,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of analyst reports. Northland Securities set a $800.00 price target on Axon Enterprise in a report on Tuesday, August 5th. Craig Hallum raised Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target for the company in a report on Tuesday, August 5th. Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the stock an “overweight” rating in a report on Friday, July 11th. UBS Group reissued a “neutral” rating and issued a $840.00 price target (up from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Finally, Piper Sandler initiated coverage on Axon Enterprise in a report on Tuesday, September 23rd. They issued an “overweight” rating and a $893.00 price target for the company. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $841.64.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $703.03 on Friday. The firm has a market capitalization of $55.19 billion, a P/E ratio of 173.59, a PEG ratio of 27.30 and a beta of 1.41. The stock has a fifty day moving average price of $755.57 and a 200 day moving average price of $713.70. Axon Enterprise, Inc has a 52 week low of $422.38 and a 52 week high of $885.91. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business’s quarterly revenue was up 32.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Hadi Partovi bought 1,358 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The stock was purchased at an average cost of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the purchase, the director owned 237,938 shares of the company’s stock, valued at $176,074,120. This trade represents a 0.57% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction dated Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the sale, the chief financial officer owned 93,592 shares of the company’s stock, valued at $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 59,932 shares of company stock valued at $45,115,616. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.